ICE agents leave a residence after knocking on the door on Jan. 28, 2026 in Minneapolis, Minnesota. The U.S. Department of Homeland Security continues its immigration enforcement operations after two ...
Mexican President Claudia Sheinbaum on Tuesday blamed Meta, Instagram's parent company, for failing to place an Artificial Intelligence tag on a fake image of alleged drug kingpin Ryan Wedding that ...
Build a local AI image generation workflow using PowerShell, Stable Diffusion and AUTOMATIC1111 on Windows 11. Install Git, Python 3.10.6, and Stable Diffusion WebUI to enable PowerShell-based AI ...
Oregon’s huge investments in addiction treatment beds began to pay off in 2025, when hundreds of new beds came online. A 74-bed Portland residential treatment center opened in July in what used to be ...
Swifties know that Taylor Swift has always been into photography, and now you can get your hands on a unique camera she was just seen using. Last Sunday, while at a Chiefs game, Taylor Swift was ...
After missing out on last month’s Feature Drop, Google is rolling out a sizable Pixel Watch 4 update this December that adds one-handed gestures. Joining Raise to Talk (which is getting a new ...
Microsoft says Windows PowerShell now warns when running scripts that use the Invoke-WebRequest cmdlet to download web content, aiming to prevent potentially risky code from executing. As Microsoft ...
HILLIARD, Ohio (WCMH) — A massive project aimed at making one of central Ohio’s busiest thoroughfares safer could begin as early as this summer. In a recent social media post, the City of Hilliard ...
Cottage cheese has been blessed with an image overhaul. Once considered a stodgy health food, it’s now a popular recipe add-in thanks to its sky-high protein content—a huge advantage in a day and age ...
Nov 6 (Reuters) - The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's (JNJ.N), opens new tab drug Caplyta as an add-on treatment for adults with major depressive ...
Oct 8 (Reuters) - The U.S. Food and Drug Administration on Wednesday cleared Regeneron Pharmaceuticals’ (REGN.O), opens new tab immunotherapy, Libtayo, as an add-on treatment for skin cancer patients ...